VALTOCO(®) (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity

Valtoco(®) is a new FDA-approved nasal spray version of diazepam indicated for the treatment of acute, intermittent, and stereotypic episodes of frequent seizure activity in epilepsy patients six years of age and older. Although IV and rectal diazepam are already used to treat seizure clusters, Valt...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornett, Elyse M., Amarasinghe, Sam N., Angelette, Alexis, Abubakar, Tunde, Kaye, Adam M., Kaye, Alan David, Neuchat, Elisa E., Urits, Ivan, Viswanath, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931041/
https://www.ncbi.nlm.nih.gov/pubmed/33670456
http://dx.doi.org/10.3390/neurolint13010007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931041/
https://www.ncbi.nlm.nih.gov/pubmed/33670456
http://dx.doi.org/10.3390/neurolint13010007

Ejemplares similares